Life Science Instrumentation Market 2019-2027 - Reuters


Life Science Instrumentation Market 2019-2027

Life Science Instrumentation Market 2019-2027 | Size, Share, Opportunities and Forecast | Credence Research

Thu May 16, 2019 - 10:30am UTC

The global life science instrumentation market was valued at US$ 57,185.5 Mn in 2018, and is expected to reach US$ 100,792.7 Mn by 2027, expanding at a CAGR of 6.5% from 2019 to 2027.

SANJOSE, United States – May 16, 2019

The latest market report published by Credence Research, Inc. “Global Life Science Instrumentation Market – Growth, Future Prospects, Competitive Analysis, 2019- 2027,” the global life science instrumentation market was valued at US$ 57,185.5 Mn in 2018, and is expected to reach US$ 100,792.7 Mn by 2027, expanding at a CAGR of 6.5% from 2019 to 2027.

Market Insights

According to the statistics provided by United Nations Population Division (UNPD), in 2017 the global death rate was 7.6 per 1000 people which is drastically low in comparison to 17.7 per 1000 people in 1960. Technological advancement in the life science instrumentation technique has been responsible in the production of highly safe and efficacious drug molecule to treat chronic illness and are utilizing the technology to provide a promising drug pipeline in the near future.

Get Sample (Free) @

Spectroscopy technique is currently dominating the technology segment for life science instrumentation market. It is a very old and reliable technique used by healthcare professionals to perform drug quality control and validation process. Its inherent features such as lack of sample preparation for quantitative and qualitative drug analysis and ease of handling are responsible for its increasing demand across life science industries. Next generation sequencing are gaining huge traction on account of its wide application in the development of personalized medicine and ability to create biological sequences for complex molecules at low cost and speed.

Pharmaceutical and biotechnology companies are the largest market holder in the end user segment for life science instrumentation market. Burgeoning requirement for novel drugs to treat chronic ailments and significant rise in initial throughput screening associated with investigation of new drug phase (IND), increases the demand of life science instrumentation technology in pharmaceutical and biotechnology companies. Diagnostic laboratories are keen to register outstanding growth in the near future owing to rising public health awareness resulting in early disease diagnosis.

North America is presently holding 32% market share and is the dominant players in the regional segment for life science instrumentation market. The chief attributing factors responsible for its positive market growth are prosing drug pipeline and existence of well developed pharmaceutical and biotechnology companies. Europe holds 30% share on account of rising prevalence of chronic disease and domicile of key players such as Merck KGaA, Illumina, Inc., Agilent Technologies, Inc. etc. Asia Pacific accounts for 25% market share owing to proactive government policies to provide financial support to drug discovery and development activities and significant rise in the number of severe adverse effects related to poor drug quality control and process validation.

Medical device producing companies actively engaged in the manufacturing of life science instrumentation technology are Agilent Technologies, Inc., Bruker Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., Merck KGaA, PerkinElmer, Inc., Shimadzu Corporation, Thermo Fisher Scientific, Inc. and Waters Corporation.

Key Market Movements:

Rising mortality rate associated with lack of effective drugs used for treating chronic diseases
Technological advancement in the techniques utilized for drugs discovery and development process
Stringent regulatory norms imposed by global healthcare agencies for manufacturing and quality control of food and drugs according to cGMP and GLP

Get Sample (Free) @

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Life Science Instrumentation Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global Life Science Instrumentation Market, by Key Players, 2018

Chapter 4. Global Life Science Instrumentation Market, by Technology
4.1. Overview
4.2. Spectroscopy
4.3. Chromatography
4.4. Polymerase Chain Reaction
4.5. Next Generation Sequencing
4.6. Clinical Chemistry Analyzers
4.7. Flow Cytometry
4.8. Immunoassays

Chapter 5. Global Life Science Instrumentation Market, by End User
5.1. Overview
5.2. Research Institutes
5.3. Pharmaceutical and Biotechnology Companies
5.4. Diagnostic Laboratories

Chapter 6. Global Life Science Instrumentation Market, by Geography

Chapter 7. Company Profiles
7.1. Agilent Technologies, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Bio-Rad Laboratories, Inc.
7.3. Bruker Corporation
7.4. Danaher Corporation
7.5. Illumina, Inc.
7.6. Merck KGaA
7.7. PerkinElmer, Inc.
7.8. Shimadzu Corporation
7.9. Thermo Fisher Scientific, Inc.
7.10. Waters Corporation

Get Sample (Free) @

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290

This content is not produced by Reuters Editorial News. It is produced by VC NewsNetwork. For content enquiry, please reach us at

Latest News >

Givaudan To Acquire Vietnamese Naturals Company Golden Frog

Givaudan, the Swiss flavors and fragrances company will be acquiring Golden Frog to strengthen its presence in the Asia Pacific region.

07:09am UTC

Bukalapak brings ecommerce services overseas with new platform

Indonesian ecommerce unicorn Bukalapak has launched BukaGlobal, a new feature that lets consumers outside Indonesia shop on the Bukalapak platform.

15:59pm UTC

KMA Group to invest US$63 million in six Centara resorts and hotels in Myanmar

This marks Centara’s entry into one of the world’s fastest-growing tourism markets and enables the company to secure a major Myanmar foothold.

04:14am UTC

Singapore Based Travellers E-Wallet Startup YouTrip Raises US$25.5M In Pre-Series A Funding

This marks the biggest funding round for a fintech company in the SEA region.

07:50am UTC

French video game maker Ubisoft expands startup programme to Singapore

The Ubisoft accelerator is bringing its startup incubator programme to Singapore for the first time.

04:03am UTC